FRA:TG5
Delisted

Frontier Resources Stock Signals

etoro logo Buy TG5
*Your capital is at risk
0.0105€
+0 (+0%)
At Close: Aug 17, 2022

Latest Data & Signals Issued

Below are some of the latest signals issued for Frontier Resources Limited

General

Signal Type Signal Value Data
Score 0.000 154 days ( 0 %
Last Price 0.0105€ 0 %
Performance History
7 Days
0.0105€ 0.0105€
0%
30 Days
0.0105€ 0.0105€
0%
12 Mos
0.0110€ 0.0105€
-4.55%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 25
Signal Type Signal Value Importance Data
High / Low N/A Very Low 0.0105€ - 0.0105€
Trend - 3 mos 0 % High Width: 0.00000000000020 %
Pred. range - 3 mos 0.0105€ - 0.0105€ Low 0 % - 0 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Aug 16, 2022 - 2 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 59.84
Signal Type Signal Value Importance Data
Trend - 12 mos -1.94 % Very High Width: 315.19 %
Pred. range - 12 mos 0.0047€ - 0.0193€ High -55.63 % - 84.20 %
Short MA 12 mos Buy Very High Jan 14, 2022 - 152 days
Long MA 12 mos Buy Very High May 20, 2022 - 64 days
Short/Long MA 12 mos Buy Very High May 20, 2022 - 64 days
Pivot Long Sell Low Aug 16, 2022 - 2 days
RSI Long Pivot Signal Buy Low Feb 03, 2022 - 138 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT FRONTIER RESOURCES LIMITED
Frontier Resources
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE